Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.
The global interventional oncology sector is poised for significant expansion, with current market analysis projecting an impressive compound annual growth rate (CAGR) of 7.94% between the years 2024 and 2034. This growth is anticipated to drive the market size from its current valuation of USD 3.48 billion to an estimated USD 8.06 billion by the year 2034.
In this rapidly evolving field, technological innovations and the surge in minimally invasive cancer treatment options are fueling industry advancements. Rising governmental support and strategic investments are key factors behind this market's robust trajectory. The introduction of cutting-edge products and innovative therapies tailored to cancer treatment is contributing significantly to the market's expansion.
The radiation therapy segment is expected to remain a dominant market force due to technological advancements and regulatory approvals. In contrast, the ablation segment is forecasted to experience the fastest growth rate, reflecting the trend toward minimally invasive cancer treatments.
When analyzing the market by cancer type, breast cancer treatments have generated substantial revenue due to the increasing prevalence and focused product developments within the sector. Meanwhile, the lung cancer segment is projected to see the swiftest growth during the forecast period, driven by partnerships, collaborations, and intensified research efforts.
Among end-users, hospitals continue to lead due to a combination of rising patient admissions, adoption of advanced medical equipment, and a concentrated effort towards research and development. Alternatively, Ambulatory Surgical Centers (ASCs) are anticipated to grow at the fastest CAGR, attributed to their cost-effectiveness and increased accessibility for patients.
North America is set to retain the largest share of the interventional oncology market, propelled by factors such as elevated cancer prevalence and technological advancements in medical imaging. In the Asia Pacific region, the market is expected to grow vigorously, bolstered by heightened awareness, research initiatives, and the introduction of new therapeutic products.
The comprehensive report segments the interventional oncology market by product type, cancer type, end-user, and region, providing a detailed analysis of current trends and potential opportunities for stakeholders in the field.
- Segmentation by Product
- Ablation Devices
- Radiation Therapy
- Particle Embolization
- Segmentation by Cancer Type
- Breast Cancer
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancer Types
- Segmentation by End-user
- Ambulatory Surgical Centers (ASCs)
- Hospitals
- Segmentation by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Companies Mentioned
- Teleflex Incorporated
- Siemens Healthineers
- Boston Scientific Corporation
- Terumo Corporation
- Hologic Inc.
- AngioDynamics
- Profound Medical
- Merit Medical
- Medtronic PLC
- Alpinion Medical Systems Co. Ltd.
With new technological advancements, strategic market initiatives, and a growing demand for non-invasive cancer therapies, the global interventional oncology market is set to redefine the oncology treatment landscape over the next decade.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023-2034 |
| Estimated Market Value (USD) in 2023 | $3.48 Billion |
| Forecasted Market Value (USD) by 2034 | $8.06 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/3lkoh8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
